Post-approval studies (Phase 4)Study completedNCT03236246
What this trial is testing
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial)
Who this might be right for
Chronic Kidney DiseasesIron Deficiency Anemia
Keryx Biopharmaceuticals 206